
California bill restricting access to weight management supplements has passed Senate Judiciary Committee
California Assembly Bill 1341, which restricts minors from purchasing dietary supplements and OTC products marketed for weight management, has been passed by the state’s Senate Judiciary Committee on June 21, 2022 by a vote of 4 to 1.
California
Opponents of the bill, namely the Natural Products Association (NPA; Washington, D.C.), state that advocates are relying on a flawed premise to draw false conclusions about dietary supplements. According to NPA, research cited by advocates of the bill do not demonstrate a causal relationship between dietary supplements and eating disorders and that FDA’s own adverse events reporting system, called MedWatch, has not had any reports indicating that consumption of weight management products has resulted in eating disorders. This is in contrast to drugs like Topiramate, which was determined by FDA to increase the risk of developing or worsening eating disorder because of MedWatch reports. The adverse events reporting system has also flagged the development of other psychiatric disorders as a results of prescription drug use, such as depression and anxiety.
While the bill’s language has softened following
Additionally, the bill states that weight management products cannot be sold to minors without a prescription from a physician. Well, not all brick-and-mortar retailers are currently set up to process prescriptions, and because of a law passed earlier this year in California, most prescriptions must be transferred electronically. This would be cost prohibitive for some small business owners to implement, says NPA.
With the bill’s passage in the Senate Judiciary, it has moved on to the Senate Appropriations Committee. If it passes Appropriations, the bill will go to the full Senate for a vote.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





